drug protocol number

Version 1.3.1

drug sponsor

Abbvie Biopharmaceuticals GmbH / KSU Liver Disease Research Center

drug study

ombitasvir \ paritaprevir \ ritonavir

drug trial site

King Abdulaziz Medical City NG (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Hospital (Jeddah)

drug status

Ongoing

drug phase